Aptevo Therapeutics Inc (APVO) Down 5.37% in Premarket Trading

Aptevo Therapeutics Inc (APVO) is lower by Tuesday morning, with the stock declining -5.37% in pre-market trading to 3.7. APVO's short-term technical score of 53 indicates that the stock has traded more bullishly over the last month than 53% of stocks on the market. In the Biotechnology industry, which ranks 84 out of 146 industries, Aptevo Therapeutics Inc ranks higher than 55% of stocks. Aptevo Therapeutics Inc has risen 9.22% over the past month, closing at $3.77 on July 5. During this period of time, the stock fell as low as $3.77 and as high as $4.50. APVO has an average analyst recommendation of Strong Buy. The company has an average price target of $28.00.

APVO has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on APVO!

See Full APVO Report

Aptevo Therapeutics Inc has a Long-Term Technical rank of 18. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 82% of the market scoring higher. In the Biotechnology industry which is number 116 by this metric, APVO ranks better than 116% of stocks.

Important Dates for Investors in APVO:

-Aptevo Therapeutics Inc is set to release earnings on 8/11/2022. Over the last 12 months, the company has reported EPS of $-6.00. -We do not have a set dividend date for Aptevo Therapeutics Inc at this time. Click Here To Get The Full Report on Aptevo Therapeutics Inc (APVO)